Bioreactor Culture Analytics for Basic Research
Maximize bioreactor culture viability and product yield with reliable analytics
RAPIDPoint® and RAPIDLab® analyzers from Siemens Healthcare Diagnostics help to maximize biomass and product yields by generating fast results for critical analytes in bioreactor cell cultures. With their small bench space requirements, microliter sample sizes, and delivery of results for multiple parameters in approximately 60 seconds, RAPIDLab and RAPIDPoint analyzers optimize cell culture environment testing right next to your bioreactor, at every stage of bioprocess development.
Our minimal-maintenance analyzers offer exceptional capabilities to support bioprocess development.
- Fast time to result improves culture monitoring when pH, pO2, and pCO2 change rapidly
- Space-saving footprint facilitates next-to-reactor analyses
- Operator interface is easy-to-use
- Automatic QC and calibration enhance quality control and improve workflow
- Flexible accommodation of different sample temperatures
RAPIDPoint 500 Analyzer
The RAPIDPoint 500 analyzer maximizes uptime with a 28-day measurement cartridge containing a full complement of analytes.
RAPIDPoint 1200 Analyzer
RAPIDLab 1200 analyzers support a full test menu and provide high throughput for incremental testing demands.
RAPIDLab 348EX Analyzer
The RAPIDLab 348EX analyzer* balances efficiency with value in the measurement of culture acid/base and electrolytes.
*Not available for sale in the U.S. Product availability varies by country.
The uses for the instruments contained herein do not require FDA approval/clearance. The users are recommended to conduct validation for testing in the cell culture environment. The FDA cleared uses for RAPIDLab and RAPIDPoint analyzers have not been cleared to test samples other than whole blood.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.